FDA Approved: MEPRON — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Mepron (atovaquone) submitted by GlaxoSmithKline LLC. The action updates the drug's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• MEPRON (ATOVAQUONE)

Snippet

SUPPL AP for MEPRON (ATOVAQUONE)